who should not take glp-1 medications glp 1 drugs Comparing GLP‑1 Drugs With Other Weight Loss Indications for GLP-1/GIP RA Summary
Description
absolute risk difference:1.1 percentage points)
Adapted from refs
Nutrients for Patients on GLP-1s
Hi everyone As we are all aware, GLP-1based therapies are transforming the obesity and metabolic disease landscape, with the market projected to cross $100B+ in the coming decade
However, data have yet to conclusively establish an association
